Read More

Tryp Therapeutics merger with Exopharm approved by shareholders

Clinical-stage psychedelic biotech, Tryp Therapeutics, Inc., has announced that its previously announced plan to merge with Exopharm Limited has received approval from Exopharm’s shareholders. The arrangement, which is expected to close on or about May 1, has satisfied all conditions precedent, with the exception of the conditional approval from the …

Read More

Missouri AG probes illegal THC sales after child illnesses

Missouri Attorney General Andrew Bailey this week launched an investigation into several companies for selling illegal vape and marijuana products that contain delta-8 and delta-9 THC, citing concerns over consumer protection and public health, particularly among children. The investigation, which also includes disposable e-cigarette products, was prompted by reports of …